Find uplifting stories about heroes, innovations, and solutions
9191 results for "weight loss medicine"
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
Researchers have created the first sex-specific brain map showing where popular weight-loss drugs like semaglutide work differently in females versus males. This breakthrough could explain why women often respond better to these treatments and pave the way for more personalized medicine.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Scientists just solved one of medicine's biggest challenges: turning injectable weight loss drugs like Ozempic into pills that work just as well. The breakthrough could help millions who avoid needles and make life-changing treatments easier to access.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.
Cancer survivors struggling with treatment-related weight gain now have a personalized path forward. Sylvester Cancer Center just launched RENEW, a 12-week program designed specifically for safe weight loss after cancer treatment.
A groundbreaking UCLA study of nearly 94,000 diverse patients discovered how genetics predict who responds best to popular weight loss medications like Ozempic. This breakthrough could transform how doctors prescribe treatments, ensuring medications work better for everyone.
India is launching affordable generic versions of popular weight-loss drugs after a key patent expired, potentially helping millions worldwide access treatments that once cost hundreds of dollars monthly. Prices could drop from $236 to just $60 per month.
The FDA just approved a convenient new weight-loss pill that works without food restrictions and could cost as little as $25 monthly with insurance. Over 3,000 people in trials lost an average of 25 pounds, and the drug starts shipping Monday.
Two major clinical trials show people can maintain their weight loss by switching to lower doses or once-daily pills after initial treatment. The findings offer hope for tackling one of obesity care's biggest challenges: keeping weight off after losing it.
Breakthrough weight loss medications like Ozempic could help tackle rising obesity rates among people living with HIV in South Africa. Early research from rural KwaZulu-Natal shows these drugs work just as well for HIV patients as everyone else.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
Showing 20 of 9191